# Michèle Milella

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michele-milella/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,489 |
| Field | Pancreatic and Hepatic Oncology Research |
| h-index | 76 |
| i10-index | 327 |
| Last Known Institution | University of Verona |
| OpenAlex ID | https://openalex.org/A5023848359 |
| ORCID iD | https://orcid.org/0000-0002-3826-5237 |
| Works | 721 |

## Researcher papers

- [Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial](https://scholariq.org/papers/erlotinib-versus-standard-chemotherapy-as-first-line-treatment-for-european/)

## Researcher topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [University of Verona](https://scholariq.org/institutions/university-of-verona/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.